High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users

Neuropsychopharmacology

Volumn 22, Issue 6, 2000, Pages 608-617

  Tuchtenhagen, Frank ^a,b,c   Daiimann, Jörg ^a   Norm, Christina ^b   Gobbelé, René ^b   Becher, Steffanie ^a   Pelz, Susanne ^b   Sass, Henning ^a   Buchner, Helmut ^b   Gouzoulis Mayfrank, Euphrosyne ^a  

^a Department of Psychiatry and Psychotherapy ^*  (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Auditory evoked potentials; Ecstasy, 3,4 methylenedioxymethamphetamine; MDMA; Neurotoxicity; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS;

ADOLESCENT; ADULT; ARTICLE; BRAIN FUNCTION; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; HUMAN; INFORMATION PROCESSING; NEUROTOXICITY; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 0034006996     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00140-2     Document Type: Article

References (62)

1. Azmitia EC, Gannon PJ (1986): The primate serotonergic system: A review of human and animal studies and a report of macaca fascicularis. Adv Neurol 43:407-468
2. Barrait ES (1985): Impulsiveness subtraits: Arousal and information processing. In Spence JT, Izard CE (eds), Motivation, Emotion, and Personality. North Holland, Elsevier, pp 137-146
3. Barrat ES, Pritchard WS, Faulk DM, Brandt ME (1987): The relationship between impulsiveness subtraits, trait anxiety, and visual N100 augmenting/reducing: A topographic analysis. Person Individ Diff 8:43-51
4. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB (1987): 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: Quantification of neurodegeneration by measurement of [3H] paroxetine-labelled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916
5. Battaglia G, Yeh SY, De Souza EB (1988): MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274
6. Benazzi F, Mazzoli M (1991): Psychiatric illness associated with "Ecstasy." Lancet 338:1520
7. Bolla Kl, McCann DU, Ricaurte GA (1998): Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 51:1532-1537
8. Bruneau N, Barthélémy C, Roux S, Jouve J, Lelord G (1989): Auditory evoked potential modifications according to clinical and biochemical responsiviness to fenfluramine treatment in children with autistic behavior. Neuropsychobiology 21:48-52
9. Buchsbaum MS, Silverman J (1968): Stimulus intensity control and cortical evoked response. Psychosom Med 30:12-22
10. Campbell MJ, Lewis DA, Foote SL, Morrison JH (1987): Distribution of choline acetyltransferase-, serotonin-, dopamine-b-hydroxylase-, tyrosine hydroxylase-immunoreactive fibers in monkey primary auditory cortex. J Comp Neurol 261:209-220
11. Carrillo-de-la-Pena MT (1992): ERP augmenting/reducing and sensation seeking: A critical review. Int J Psychophysiol 12:211-220
12. Carrillo-de-la-Pena MT (1998): Effect of stimulus intensity and order of stimulus presentation on auditory evoked potentials (AEPs). An analysis of the consistency of augmenting/ reducing (A/R) Phenomenon. Int J Psychophysiol Nr 12:214
13. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G (1995): Reorganization of ascending 5-HAT axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). J Neuroscience 15:5476-5485
14. Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delsignore R (1998): Serotonergic function after 3,4-methylenedioxymethamphetamine (Ecstasy) in humans. Intern Clin Psychopharmacol 13:1-9
15. Gouzoulis-Mayfrank E, Hermle L, Kovar K- A, Sass H (1996): The entactogens: "Ecstasy" (MDMA), "Eve" (MDE) and other ring-substituted methamphetamine derivatives. A novel pharmacological class among the illicit designer drugs? Nervenarzt 67:369-380
16. Green AR, Cross AJ, Goodwin GM (1995): Review of the pharmacology and clinical pharmacology of 3,4-methyIenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology 119:246-260
17. Hegerl U, Juckel G (1993): Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis. Biol Psychiat 33:173-187
18. Hegerl U, Ulrich G, Müller-Oerlinghausen B (1987): Auditory evoked potentials and response to lithium prophylaxis. Pharmacopsychiatry 20:213-216
19. Hegerl U, Prochno I, Ulrich G, Müller-Oerlinghausen B (1989): Sensation seeking and auditory evoked potentials. Biol Psychiat 25:179-190
20. Hegerl U, Juckel G, Rao ML, Müller-Oerlinghausen B (1991): Blood serotonin and auditory evoked potentials under fluvoxamine challenge and phototherapy. In Cassano GB, Akiskal HS (eds), Serotonin-Related Psychiatric Syndromes: Clinical and Therapeutic Links. London, Royal Society of Medicine, pp 163-170
21. Hegerl U, Wulff H, Müller-Oerlinghausen B (1992): Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: A replication study. Psychiat Res 44:181-191
22. Hegerl U, Gallinat J, Mrowinski D (1994): Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17:1-13
23. Hegerl U, Gallinat J, Mrowinski D (1995a): Sensory cortical processing and the biological basis of personality. Biol Psychiat 37:467-472
24. Hegerl U, Lipperheide K, Juckel G, Schmidt LG, Rommelspacher H (1995b): Antisocial tendencies and cortical sensory evoked responses in alcoholism. Alcohol Clin Exp Res 19:31-36
25. Hegerl U, Juckel G, Müller HJ (1996): Event-related cortical potentials as indicators of neurochemical dysfunction in psychiatric patients. Nervenarzt 67:360-368
26. Juckel G, Schmidt LG, Rommelspacher H, Hegerl U (1994): The tridimensional personality questionnaire and the intensity dependence of auditory evoked dipole source activity. Biol Psychiat 37:311-317
27. Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR (1992): Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: Effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18:331-341
28. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH (1987): The distribution of tyrosine hydroxylaseimmunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci 7:279-290
29. Lukas JH (1987): Human augmenting-reducing and sensation seeking. Psychophysiol 19:333-334
30. McCann DU, Ricaurte GA (1991): Lasting neuropsychiatrie sequelae of (+)-methylenedioxymethamphetamine ("Ecstasy") in recreational users. J Clin Psychopharmacol 11:302-305
31. McCann DU, Szabo Z, Scheffel U, Dannais RF, Ricaurte GA (1998): Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 352:1433-1437
32. McGuire PK, Cope H, Fahy TA (1994): Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ("Ecstasy"). Br J Psychiat 165:391-395
33. Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn EG, Wilson MA (1990): Neurotoxicity of MDMA and related compounds. Ann NY Acad Sei 600:640-646
34. Morgan MJ (1998): Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252-264
35. Morgan MJ (1999): Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology 141:30-36
36. Morrison JH, Foote SL (1986): Noradrenergic and serotonergic innervation of cortical, thalamic, and tectal visual structures in old and new world monkeys. J Comp Neurol 243:117-138
37. Naatanen R, Picton T (1987): The Nl wave of the human electric and magnetic response to sound: A review and an analysis of the component structure. Psychophysiology 24:375-425
38. O'Hearn EG, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988): Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803
39. Pallanti S, Mazzi D (1992): MDMA (Ecstasy) precipitation of panic disorder. Biol Psychiat 32:91-95
40. Parrott AC, Lasky J (1998): Ecstasy (MDMA) effects upon mood and cognition: Before, during, and after a Saturday night dance. Psychopharmacology 139:261-268
41. Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K (1998): Cognitive performance in recreational users of MDMA ("ecstasy"): Evidence for memory deficits. J Psychopharmacol 12:79-83
42. Price LH, Ricaurte GA, Krystal JH, Heninger GR (1989): Neuroendocrine and mood responses to intravenous L-tryptophane in MDMA users. Arch Gen Psychiat 46:20-22
43. Raine A (1989): Evoked potentials and psychopathy. Int J Psychophysiol 8:1-16
44. Raine A, Venables PH (1990): Evoked potential augmentingreducing in psychopaths and criminals with impaired smooth-pursuit eye movements. Psychiat Res 31:85-98
45. Ricaurte GA, Bryan G, Strauss L, Seiden L, Schuster C (1985): Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229:986-988
46. Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Längsten JW (1988): MDMA selectively damages central serotonergic neurons in the primate. JAMA 260:51-55
47. Ricaurte GA, Martello AL, Katz JL, Martello MB (1992): Lasting effects of MDMA on central serotonergic neurons in nonhuman primates: Neurochemical observations. J Pharmacol Exp Ther 261:616-622
48. Scherg M (1991): Akustisch evozierte Potentiale-Grundlagen, Entstehungsmechanismen, Quellenmodell. Stuttgart: Kohlhammer
49. Scherg M, Vajsar J, Picton TW (1989): Source analysis of the late human auditory evoked potentials. J Cogn Neurosci 4:336-355
50. Schmidt CJ (1987): Acute administration of methylenedioxymethamphetamine: Comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs. Eur J Pharmacol 136:81-88
51. Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999): Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users. Br J Psychiat 175: 63-69
52. Stenberg G, Rosen I, Risberg J (1988): Personality and augmenting/reducing in visual and auditory potentials. Person Indiv Diff 9:571-579
53. Takeuchi Y, Sano Y (1983): Immunohistochemical demonstration of serotonin nerve fibers in the neocortex of the monkey (Macaca fuscata). Anat Embryol 166:155-168
54. Von Knorring L (1982): Effect of imipramine and zimelidine on the augmenting-reducing response of visual-evoked potentials in healthy volunteers. Adv Biol Psychiat 9:81-86
55. Von Knorring L, Perris C (1981): Biochemistry of augmenting/reducing response in visual evoked potentials. Neurophysiol 7:1-8
56. Von Knorring L, Johansson F, Almay B (1980): Augmenting/ reducing response in visual evoked potentials with chronic pain syndromes. Adv Biol Psychiat 4:55-62
57. Wilson MA, Ricaurte GA, Molliver ME (1989): Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-MethyIenedioxymethamphetamine. Neuroscience 28:121-137
58. Zuckerman M (1972): Drug usage as one manifestation of a "sensation-seeking" trait. In Keup W (ed), Drug Abuse: Current Concepts and Research. Springfield, IL: Charles C. Thomas, pp 154-163
59. Zuckerman M (1990): The psychophysiology of sensation seeking. J Pers 58:313-345
60. Zuckerman M, Murtaugh T, Siegel J (1974): Sensation seeking and cortical augmenting/ reducing. Psychophysiology 11:535-542
61. Zuckerman M, Eysenck SPG, Eysenck HJ (1978): Sensation seeking in England and America. J Consult Clin Psychol 46:477-482
62. Zuckerman M, Simons R, Como PG (1988): Sensation seeking and stimulus intensity as modulators of cortical, cardiovascular, and electrodermal response: A crossmodality study. Person Indiv Diff 9:361-372